Medical Research

AI around the globe: Pathologists and Scientists at multiple Charles River Laboratories’ locations use Aiforia Create  Ten different pathologists and scientists spread around the world are all sharing an Artificial Intelligence (AI)...

American Cancer Society says advances in treating lung and skin cancers contributed to the 2.2% drop in cancer mortality By Brianna Abbott - WSJ The cancer death rate in the U.S. dropped 2.2% from 2016 to 2017, the largest single-year...

These twelve artificial intelligence innovations are expected to start impacting clinical care by the end of the decade. By Jennifer Bresnick of HeatlhITAnalytics.com There’s no question that artificial intelligence is moving...

Number of patients eligible for genome-driven oncology therapy is increasing, but the percentage who reportedly benefit from the therapy remains at less than 5% Advances in precision medicine in oncology (precision oncology) are fueling...

Dear Reader, This is a survey to better understand the drivers for AI in Digital Pathology and what you consider to be the key enablers/blockers to adoption. We have created a short list of questions and the survey will not take more than...

Aiforia announced today the release of its new product, the CE-IVD marked Aiforia® Clinical, as well as the award of €2.2 million in funding from the EU’s Horizon 2020 program. The EU grant was awarded to support Aiforia’s ongoing...